Publications by authors named "Axel Zander"

Claim this Profile
A
Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamide.
Andrew D Trunk, Sagar S Patel, Josef T Prchal, Douglas W Sborov, Axel R Zander

Leuk Res Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Anti-T-lymphocyte globulin dosing on GVHD and Immune reconstitution in matched unrelated myeloablative peripheral blood stem cell transplantation.
Radwan Massoud, Evgeny Klyuchnikov, Nico Gagelmann, Tatiana Zabelina, Christine Wolschke, Axel Zander

Bone Marrow Transplant· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA metabarcoding reveals changes in the contents of carnivorous plants along an elevation gradient.
Joanne E Littlefair, Axel Zander, Clara de Sena Costa, Elizabeth L Clare

Mol Ecol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Results of Prophylactic Donor Lymphocyte Infusions for Patients with Multiple Myeloma after Allogeneic Stem Cell Transplantation.
Maximilian Gröger, Nico Gagelmann, Christine Wolschke, Ute-Marie von Pein, Evgeny Klyuchnikov, Axel Zander

Biol Blood Marrow Transplant· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability and Priority of Symptoms and Symptom Clusters Among Allogeneic HSCT Patients Within a 5-Year Longitudinal Study.
Peter Esser, Katharina Kuba, Angela Scherwath, Christoffer Johansen, Anke Schwinn, Axel Rolf Zander

J Pain Symptom Manage· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
Eolia Brissot, Myriam Labopin, Matthias Stelljes, Gerhard Ehninger, Rainer Schwerdtfeger, Axel R Zander

J Hematol Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of temperature variability on community structure in a natural microbial food web.
Axel Zander, Louis-Félix Bersier, Sarah M Gray

Glob Chang Biol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted Mice.
Pierre Abramowski, Susanne Krasemann, Thomas Ernst, Claudia Lange, Harald Ittrich, Axel R Zander

Stem Cells Dev· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-MSCs: successful fusion of MSCs with β-cells results in a β-cell like phenotype.
Zahra Azizi, Claudia Lange, Federico Paroni, Amin Ardestani, Anke Meyer, Axel R Zander

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Top predators affect the composition of naive protist communities, but only in their early-successional stage.
Axel Zander, Dominique Gravel, Louis-Félix Bersier, Sarah M Gray

Oecologia· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for survival of patients with newly diagnosed chronic GVHD according to NIH criteria.
Francis Ayuk, Ronja Veit, Tatjana Zabelina, Lara Bussmann, Maximilian Christopeit, Axel R Zander

Ann Hematol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory effects of the ether phospholipid edelfosine in experimental autoimmune encephalomyelitis.
Pierre Abramowski, Karin Steinbach, Axel R Zander, Roland Martin

J Neuroimmunol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum albumin level predicts survival of patients with gastrointestinal acute graft-versus-host disease after allogeneic stem cell transplantation.
Francis Ayuk, Lara Bussmann, Tatjana Zabelina, Ronja Veit, Haefaa Alchalby, Axel R Zander

Ann Hematol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic cytotoxic activity of treosulfan and gemcitabine in pancreatic cancer cell lines.
Emilia Nitsch, Sormeh Mina, Ingo Brammer, Andrea Pace, Gunter Schuch, Axel Zander

Anticancer Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study.
Angela Scherwath, Lena Schirmer, Margitta Kruse, Gundula Ernst, Matthias Eder, Axel R Zander

Psychooncology· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
Anthony Oyekunle, Axel R Zander, Mascha Binder, Francis Ayuk, Tatjana Zabelina

Ann Hematol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.
Nicolaus Kröger, Anita Badbaran, Tatjana Zabelina, Francis Ayuk, Christine Wolschke, Axel R Zander

Biol Blood Marrow Transplant· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding study.
Christine Wolschke, Thomas Stübig, Ute Hegenbart, Stefan Schönland, Marion Heinzelmann, Axel Zander

Exp Hematol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial.
Jürgen Finke, Claudia Schmoor, Wolfgang A Bethge, Hellmut D Ottinger, Matthias Stelljes, Axel R Zander

Biol Blood Marrow Transplant· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting.
Evgeny Klyuchnikov, Ernst Holler, Martin Bornhäuser, Guido Kobbe, Arnon Nagler, Axel R Zander

Br J Haematol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Arnon Nagler, Myriam Labopin, Avichai Shimoni, Dietger Niederwieser, Ghulam J Mufti, Axel R Zander

Biol Blood Marrow Transplant· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of interleukin 16 in multiple myeloma.
Djordje Atanackovic, York Hildebrandt, Julia Templin, Yanran Cao, Christiane Keller, Axel R Zander

J Natl Cancer Inst· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk models predicting survival after reduced-intensity transplantation for myelofibrosis.
Haefaa Alchalby, Dinah-Rohina Yunus, Tatjana Zabelina, Guido Kobbe, Ernst Holler, Axel R Zander

Br J Haematol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug dosing and monitoring in obese patients undergoing allogenic stem cell transplantation.
Claudia Langebrake, Friederike Bernhardt, Michael Baehr, Nicolaus Kröger, Axel R Zander

Int J Clin Pharm· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular diagnostics, targeted therapy, and the indication for allogeneic stem cell transplantation in acute lymphoblastic leukemia.
Anthony Oyekunle, Torsten Haferlach, Nicolaus Kröger, Evgeny Klyuchnikov, Axel Rolf Zander

Adv Hematol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis